Proposed cuts to the National Institutes of Health and the National Science Foundation “would cause immense and largely ...

People are going on social media to share their belief that this antiparasitic drug can fight cancer. Learn what the science ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

This leads to problems with coordination and movement, a condition known as ataxia. "Our research looked at brain tissue ... The team also used a well-established mouse model known as experimental ...

SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Design ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

A noninvasive therapy delivering gentle spinal stimulation was shown to slow disease progression and extend survival in an ...

After nearly 15 years' research, scientists at the UdeM-affiliated CHU Sainte-Justine have developed a compound that has ...

The enzyme AMPD1 plays a key role in muscle energy production and normal muscular function. Loss of AMPD1 activity due to ...

Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a progressive neurological disease with an ...